BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bai J, Wu J, Tang R, Sun C, Ji J, Yin Z, Ma G, Yang W. Emodin, a natural anthraquinone, suppresses liver cancer in vitro and in vivo by regulating VEGFR2 and miR-34a. Invest New Drugs. 2020;38:229-245. [PMID: 30976957 DOI: 10.1007/s10637-019-00777-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Li FY, Fan TY, Zhang H, Sun YM. Demethylation of miR-34a upregulates expression of membrane palmitoylated proteins and promotes the apoptosis of liver cancer cells. World J Gastroenterol 2021; 27(6): 470-486 [PMID: 33642822 DOI: 10.3748/wjg.v27.i6.470] [Reference Citation Analysis]
2 Singh S, Raza W, Parveen S, Meena A, Luqman S. Flavonoid display ability to target microRNAs in cancer pathogenesis. Biochem Pharmacol 2021;189:114409. [PMID: 33428895 DOI: 10.1016/j.bcp.2021.114409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yin J, Yin Q, Liang B, Mi R, Ai H, Chen L, Wei X. RETRACTED ARTICLE: Chrysophanol suppresses growth and metastasis of T cell acute lymphoblastic leukemia via miR-9/PD-L1 axis. Naunyn-Schmiedeberg's Arch Pharmacol 2020;393:273-86. [DOI: 10.1007/s00210-019-01778-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zobeiri M, Parvizi F, Kalhori MR, Majnooni MB, Farzaei MH, Abdollahi M. Targeting miRNA by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty Liver. Evid Based Complement Alternat Med 2021;2021:6641031. [PMID: 34426744 DOI: 10.1155/2021/6641031] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Huang H, Liu Z, Qi X, Gao N, Chang J, Yang M, Na S, Liu Y, Song R, Li L, Chen G, Zhou H. Rhubarb granule promotes diethylnitrosamine-induced liver tumorigenesis by activating the oxidative branch of pentose phosphate pathway via G6PD in rats. J Ethnopharmacol 2021;281:114479. [PMID: 34343647 DOI: 10.1016/j.jep.2021.114479] [Reference Citation Analysis]
6 Gao L, Gou N, Yao M, Amakye WK, Ren J. Food-derived natural compounds in the management of chronic diseases via Wnt signaling pathway. Crit Rev Food Sci Nutr 2021;:1-31. [PMID: 33554630 DOI: 10.1080/10408398.2021.1879001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lee J, Han Y, Wang W, Jo H, Kim H, Kim S, Yang KM, Kim SJ, Dhanasekaran DN, Song YS. Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy. Biomolecules 2021;11:1107. [PMID: 34439774 DOI: 10.3390/biom11081107] [Reference Citation Analysis]
8 Zhao J, Wang Y, Han M, Lu H, Chen X, Liu S, Yuan X, Han K, Liang P, Cheng J. P7TP3 inhibits tumor development, migration, invasion and adhesion of liver cancer through the Wnt/β-catenin signaling pathway. Cancer Sci 2020;111:994-1007. [PMID: 31746531 DOI: 10.1111/cas.14243] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
9 McDonald SJ, VanderVeen BN, Velazquez KT, Enos RT, Fairman CM, Cardaci TD, Fan D, Murphy EA. Therapeutic Potential of Emodin for Gastrointestinal Cancers. Integr Cancer Ther 2022;21:15347354211067469. [PMID: 34984952 DOI: 10.1177/15347354211067469] [Reference Citation Analysis]
10 Tuli HS, Aggarwal V, Tuorkey M, Aggarwal D, Parashar NC, Varol M, Savla R, Kaur G, Mittal S, Sak K. Emodin: A metabolite that exhibits anti-neoplastic activities by modulating multiple oncogenic targets. Toxicology in Vitro 2021;73:105142. [DOI: 10.1016/j.tiv.2021.105142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Shen P, Han L, Chen G, Cheng Z, Liu Q. Emodin Attenuates Acetaminophen-Induced Hepatotoxicity via the cGAS-STING Pathway. Inflammation 2021. [PMID: 34409550 DOI: 10.1007/s10753-021-01529-5] [Reference Citation Analysis]
12 Li Y, Li Y, Zhang J, Ji L, Li M, Sun X, Feng H, Yu Z, Gao Y. Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma. JHC 2022;Volume 9:41-56. [DOI: 10.2147/jhc.s346047] [Reference Citation Analysis]
13 Mirzaei S, Hushmandi K, Zabolian A, Saleki H, Torabi SMR, Ranjbar A, SeyedSaleh S, Sharifzadeh SO, Khan H, Ashrafizadeh M, Zarrabi A, Ahn KS. Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies. Molecules 2021;26:2382. [PMID: 33921908 DOI: 10.3390/molecules26082382] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
14 Qi L, Jiang-Hua M, Ge-Liang H, Qing C, Ya-Ming L. MiR-34a Inhibits Spinal Cord Injury and Blocks Spinal Cord Neuron Apoptosis by Activating Phatidylinositol 3-kinase (PI3K)/AKT Pathway Through Targeting CD47. Curr Neurovasc Res 2019;16:373-81. [PMID: 31490756 DOI: 10.2174/1567202616666190906102343] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
15 Zhang FY, Li RZ, Xu C, Fan XX, Li JX, Meng WY, Wang XR, Liang TL, Guan XX, Pan HD, Liu L, Yao XJ, Wu QB, Leung EL. Emodin induces apoptosis and suppresses non-small-cell lung cancer growth via downregulation of sPLA2-IIa. Phytomedicine 2021;:153786. [PMID: 34785104 DOI: 10.1016/j.phymed.2021.153786] [Reference Citation Analysis]
16 Akkol EK, Tatlı II, Karatoprak GŞ, Ağar OT, Yücel Ç, Sobarzo-Sánchez E, Capasso R. Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin. Cancers (Basel) 2021;13:2733. [PMID: 34073059 DOI: 10.3390/cancers13112733] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Sougiannis AT, Enos RT, VanderVeen BN, Velazquez KT, Kelly B, McDonald S, Cotham W, Chatzistamou I, Nagarkatti M, Fan D, Murphy EA. Safety of natural anthraquinone emodin: an assessment in mice. BMC Pharmacol Toxicol 2021;22:9. [PMID: 33509280 DOI: 10.1186/s40360-021-00474-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Zheng Q, Li S, Li X, Liu R. Advances in the study of emodin: an update on pharmacological properties and mechanistic basis. Chin Med 2021;16:102. [PMID: 34629100 DOI: 10.1186/s13020-021-00509-z] [Reference Citation Analysis]
19 Tian J, Li J, Bie B, Sun J, Mu Y, Shi M, Zhang S, Kong G, Li Z, Guo Y. MiR-3663-3p participates in the anti-hepatocellular carcinoma proliferation activity of baicalein by targeting SH3GL1 and negatively regulating EGFR/ERK/NF-κB signaling. Toxicol Appl Pharmacol 2021;420:115522. [PMID: 33838155 DOI: 10.1016/j.taap.2021.115522] [Reference Citation Analysis]
20 Fu K, Wang C, Ma C, Zhou H, Li Y. The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity. Front Pharmacol 2021;12:771459. [PMID: 34803712 DOI: 10.3389/fphar.2021.771459] [Reference Citation Analysis]
21 Xue X, Quan Y, Gong L, Gong X, Li Y. A review of the processed Polygonum multiflorum (Thunb.) for hepatoprotection: Clinical use, pharmacology and toxicology. J Ethnopharmacol 2020;261:113121. [PMID: 32693115 DOI: 10.1016/j.jep.2020.113121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]